LOS ANGELES, July 12 /PRNewswire-FirstCall/ -- Universal Detection Technology (OTC Bulletin Board: UDTT; FWB: P08) (http://www.udetection.com/), a developer of early-warning monitoring technologies to protect people from bio-terrorism and other infectious health threats, announced today that it has introduced the second generation of BSM-2000 with new features and capabilities. The new generation is equipped with a self-calibration mechanism that will automatically calibrate the instrument between each test and possesses a stronger pump that will increase the sensitivity of the device.
"Through our extensive testing we realized that in the realm of 'bio-detection' the sample collection method is just as important as the sample detection method. Therefore, we set out to compliment our robust detection system with a more powerful pump and a better filter medium for collection of the samples," said Amir Ettehadieh, UDTT's Director of R&D.
About Universal Detection Technology
Universal Detection Technology (UDTT), founded in 1973, is a developer of monitoring technologies, including bio-terrorism detection devices. Universal Detection Technology, in cooperation with NASA's Jet Propulsion Laboratory (JPL) has developed the BSM-2000, a bacterial spore and anthrax spore monitoring device, which combines JPL's spore detection technology with UDTT's aerosol capture device. For more information, please visit http://www.udetection.com/.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt; our ability to timely and cost effectively complete the development and testing of our products; our ability to commercially produce our products on a profitable basis; commercial acceptance of our products; product price volatility; product demand; market competition and general economic conditions; and other factors described in UDTT's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
